VA study shares genetic findings to help veterans control cholesterol
NCT ID NCT04178122
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a way to give veterans their genetic test results that show a higher risk for heart disease. 112 veterans took part. The goal was to see if sharing this information helps them lower their cholesterol and improve their health. The study focused on developing the process and measuring its impact.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- genetic test result disclosure and counseling
- What this could lead to
- If successful, this could show how returning genetic results to veterans helps them manage heart disease risk better.
- What could go wrong
- This is a small, completed study focused on developing a process, not testing a treatment. Results may not apply to all veterans or other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
112 people
The number who actually took part.
- Started
-
Feb 2020
- Finished
-
Sep 2024
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Living enrollee in MVP * Is identified to have a pathogenic or likely pathogenic variant in the gene(s) of interest in MVP genotype data Exclusion Criteria: * Previously underwent genetic testing for the condition of interest * Is incarcerated * Is pregnant
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130-4817, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can calming inflammation shield the heart?
- Could artery disease drain the body's repair cells?
- Can hidden blood mutations ignite heart disease?
- Could tiny heart vessels hold the key to a common form of heart failure?
- Could an old malaria drug shield hearts in kidney disease?